Brian McNamee
Fortune : 10 M $ au 30/06/2026
Fortune : 10 M $ au 30/06/2026
Brian Anthony McNamee is Chairman at CSL Ltd. since 2018.
Holds the position of Chairman & Independent Non-executive Director at CSL Behring LLC.
Serves as Chairman of the Geoff Ogilvy Foundation since 2021.
Acts as Director at CSL Innovation Pty Ltd. Formerly Chief Executive Officer, Executive Director & MD at CSL Ltd. from 2012 to 2013.
Served as Chairman at Genesis Care Pty Ltd. from 2019 to 2022.
Was Director at Gen-Probe, Inc. during 2002 to 2007 and again from 2010 to 2011.
Held the role of Managing Director at Pacific Biotechnology Ltd. Served as Director at Peter Maccallum Cancer Foundation Ltd. Worked as General Manager-Faulding Product Divisions at FH Faulding & Co. Ltd. Was President at CSL Behring LLC.
Acted as Principal at Tarnagulla Ventures Pty Ltd. Completed undergraduate and doctorate degrees at the University of Melbourne, with the doctorate conferred in 1979.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CSL LIMITED 0,03 % | 17/02/2026 | 127 628 ( 0,03 % ) | 10 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Directeur/Membre du Conseil | - |
| CSL LIMITED | Président | 17/10/2018 |
Geoff Ogilvy Foundation | Président | 01/05/2021 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Président | 01/06/2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | President | 01/07/2013 |
| CSL LIMITED | President | 01/07/2013 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Directeur/Membre du Conseil | 31/05/2007 |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FH Faulding & Co. Ltd.
FH Faulding & Co. Ltd. Pharmaceuticals: MajorHealth Technology Produces and wholesales pharmaceutical, household and allied products | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Provides cancer care services | Health Services |
Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures invests in companies located across the globe, primarily in Australia and the United States. The firm focuses on life science and healthcare sectors. It participates in seed and early stage capital requirements. | Finance |
Geoff Ogilvy Foundation |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national